2020
The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM).
Adelson K, Canavan M, Mun S, Gross C, Sinanis N, Davidoff A. The association between clinical trial (CT) participation, pharmaceutical costs, and savings performance in the Oncology Care Model (OCM). Journal Of Clinical Oncology 2020, 38: 2-2. DOI: 10.1200/jco.2020.38.29_suppl.2.Peer-Reviewed Original ResearchOncology Care ModelDrug costsCancer CenterLung cancerEpisode costsMean MedicareYale Cancer CenterClinical trial participationSystemic cancer therapyPart D drug costsCancer therapyLower drug costsCommon cancer typesChi-square testPayment modelsClinical factorsNovel cancer therapiesTrial participationOvarian cancerPatient episodesNovel therapiesCare modelCTR groupPharmaceutical costsAlternative payment models
1999
Factors Affecting Prophylactic Oophorectomy in Postmenopausal Women
GROSS C, NICHOLSON W, POWE N. Factors Affecting Prophylactic Oophorectomy in Postmenopausal Women. Obstetrics And Gynecology 1999, 94: 962-968. DOI: 10.1097/00006250-199912000-00011.Peer-Reviewed Original ResearchConceptsVaginal hysterectomyConcomitant oophorectomyProphylactic oophorectomyTotal abdominal hysterectomyWomen 50 yearsHospital discharge databasePhysician practice styleCross-sectional studyMultiple logistic regressionType of procedureOophorectomy ratesAbdominal hysterectomyPostmenopausal womenPatient factorsSurgical morbidityNonclinical factorsDischarge databaseOvarian cancerOophorectomyHysterectomyCase volumeBenign conditionsPractice styleLogistic regressionIndependent effects